[Opinion]Research and development accounts for only about 17 percent of total spending at most big pharma companies. Faculty Associate Gerard Anderson is quoted.
News & Announcements
Opponents of the role of consumers and markets in health care have one go-to argument above all others: that you can’t shop for health care when you’re unconscious. The rising problem of gargantuan, surprise medical bills in surgical wards and emergency rooms shows that they have a point. The good news is that constructive, bipartisan […]
Even as Congress holds hearings and the White House proposes updating rules for drug pricing, Maryland and some other states are also searching for ways to make prescription medications more affordable. Faculty Associate Gerard Anderson is featured.
Fentanyl test strips can detect the presence of the deadly drug in other drugs, such as OxyContin. But the strips could be considered drug paraphernalia under Arizona law. Faculty Associate Susan Sherman is interviewed.
As Philadelphia works to connect more people in Kensington who struggle with opioid addiction to health care and social services, it’s getting help from an unlikely partner: the Philadelphia Police Department. Faculty associate Susan Sherman is quoted.
Pennsylvania Attorney General Josh Shapiro accused a major nonprofit hospital system and health insurer of failing to fulfill its charitable mission Thursday, taking a step into a bruising, years-long regional health-care battle that has become emblematic of how broader changes rippling through the health-care system can leave sick people caught in the crossfire of competition between multibillion-dollar […]
Congress on Tuesday jumped into its first round of hearings on drug prices for the year, vowing to take action on a problem that the president and the public see as a top concern for the country. Gerard Andersonis featured.
To expand their reach, flagship hospitals including Mayo, the Cleveland Clinic and Houston’s MD Anderson Cancer Center have signed affiliation agreements with smaller hospitals around the country. Gerard Anderson is quoted.
In a practice that policy experts say smothers competition and keeps prices high, drug companies routinely make hidden pacts with middlemen that effectively block patients from getting cheaper generic medicines. Faculty Associate Gerard Anderson, lead author of the JHSPH study, is quoted.
Drug companies routinely make hidden pacts with middlemen that effectively block patients from getting cheaper generic medicines. Faculty Associate Gerard Anderson is quoted.